Merck & Co., Inc. (MRK) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $148.78 +0.54%
EPS Growth %: -14.3%
Financial Fact:
Other (income) expense, net: -3.28B
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -14.3%
Financial Fact:
Other (income) expense, net: -3.28B
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $1.05, $0.04 better than the analyst estimate of $1.01. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $12.16 billion.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- KLX Energy narrows Q3 2026 revenue guidance, completes rights offering
- This Is The Top REIT Stock Stifel Analysts Are Backing Right Now
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
